Gene editing: The next frontier in America’s abortion wars
By Sarah Karlin,
Politico
| 02. 16. 2016
[cites CGS' Marcy Darnovsky]
Untitled Document
Longtime combatants find themselves on the same side when it comes to manipulating the DNA of human embryos.
That may seem like an idea from a sci-fi flick, but it’s already here. The gene-editing technique is already used in research and has the potential to modify human DNA with unprecedented ease in the not-too-distant future. British regulators approved limited experiments in human embryos earlier this month.
The technology holds promise to cure diseases like cystic fibrosis or sickle cell and even revive extinct species. But critics fear it could also be harnessed to craft “designer babies,” who are more intelligent, beautiful or athletic and to “edit” embryonic cells to change an inherited trait forever.
Those dystopian prospects have aligned U.S. groups long at odds: The anti-abortion Susan B. Anthony List, Family Research Council and the Center for Bioethics and Culture oppose gene editing in embryos. So do abortion rights groups like Our Bodies Ourselves and the leadership of the Pro Choice Alliance for Responsible Research, albeit for very different reasons.
They’re not alone in raising concerns. Scientists...
Related Articles
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Nick Paul Taylor, Fierce Biotech | 01.09.2026
Menlo Ventures has made a $16 million bet that the “baby KJ” custom CRISPR therapy success story is repeatable. The funding has enabled CRISPR co-inventor Jennifer Doudna, Ph.D., and baby KJ scientist Fyodor Urnov, Ph.D., to launch Aurora...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...